Gemue puts automation inside
Pneumatic aseptic valves offer reduced installation costs and minimise faults
In the past, users needed three products to establish a functional unit – a valve, a solenoid and a switchbox, which had to be assembled using valve-specific mounting kits. Valve, measurement and control system company Gemue says the 651 provides a complete solution. It requires little mechanical installation and is ready for operation within just a few minutes thanks to the SpeedAP function. An analogue travel sensor continuously detects the valve position and the data is evaluated via a microprocessor.
The Gemue 651 is available as an open/close valve or with integrated positioner as a control valve in the nominal sizes DN 4–25. The maximum permissible operating pressure is 10 bar with EPDM diaphragms and 6 bar with PTFE diaphragms. The maximum permissible operating temperature during sterilisation is 150°C. The valve is CIP/SIP capable. Its compact design makes it ideally suitable for use where space is at a premium, for example within valve batteries and as a component of valve blocks in multi-port design. The pneumatic actuator section of the housing is made from stainless steel, while the automation module located above is made from PP (polypropylene).
Gemue says the essential advantages for the customer are: lower price; reduced installation costs; and reduced operating costs.
The valve is GMP-compatible, minimises potential faults such as leakages, connection and mounting errors as a result of integration and offers simplified logistics and materials management because there is now only one article number for the complete valve.
You may also like
Trending Articles
You may also like
Manufacturing
BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech
The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing
Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform
The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing
Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market
Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA